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 Abstract 
 Nutrigenetics considers the influence of individual genetic variation on differences in response 
to dietary components, nutrient requirements and predisposition to disease. Nutrigenomics 
involves the study of interactions between the genome and diet, including how nutrients af-
fect the transcription and translation process plus subsequent proteomic and metabolomic 
changes, and also differences in response to dietary factors based on the individual genetic 
makeup. Personalized characteristics such as age, gender, physical activity, physiological state 
and social status, and special conditions such as pregnancy and risk of disease can inform di-
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etary advice that more closely meets individual needs. Precision nutrition has a promising fu-
ture in treating the individual according to their phenotype and genetic characteristics, aimed 
at both the treatment and prevention of disease. However, many aspects are still in progress 
and remain as challenges for the future of nutrition. The integration of the human genotype 
and microbiome needs to be better understood. Further advances in data interpretation tools 
are also necessary, so that information obtained through newer tests and technologies can be 
properly transferred to consumers. Indeed, precision nutrition will integrate genetic data with 
phenotypical, social, cultural and personal preferences and lifestyles matters to provide a more 
individual nutrition, but considering public health perspectives, where ethical, legal and policy 
aspects need to be defined and implemented.  © 2016 S. Karger AG, Basel 
 Introduction 
 Recognition of diverse individual nutritional needs and responses to diet are changing 
standards of nutritional care, creating new possibilities for personalization  [1] . In the fol-
lowing, the term nutrigenetics will refer to interactions of inherited DNA sequence variants 
with individual nutrients, while the term nutrigenomics, in the narrow sense, will refer to 
nutrition-related DNA modifications and to regulatory interactions of nutrients and bioactive 
food components with DNA and RNA elements  [2] .
 Thus, nutrigenetics considers the influence of individual genetic variation on differences 
in response to dietary components, nutrient requirements and predisposition to disease  [3] . 
Not all single-nucleotide polymorphisms (SNPs), however, influence gene transcription and 
the protein structure  [4] because some changes in nitrogenous bases will not be reflected in 
an amino acid change leading to protein expression. On the other hand, broadly speaking, 
nutrigenomics includes the study of interactions between the genome and diet, including how 
nutrients affect the transcription and translation process plus subsequent proteomic and 
metabolomic changes, and also differences in response to dietary factors based on individual 
genetic makeup  [5] .
 Characteristics such as age, gender, physical activity, physiological state and social status, 
and special conditions such as pregnancy and risk of disease  [6] can inform dietary advice 
that more closely meets individual needs  [7] . In this context, the USDA indicated published 
new population nutrition guidelines in 2016, where the individual nutrition to meet person-
alized cultural and traditional preferences is included in the new recommendations  [8] . Nutri-
genetics and nutrigenomics would be ideal tools for informing such guidelines on person-
alized nutrient intake.
 Current views on personalized nutrition encompass omics technologies, functional foods, 
genetic products, future endeavors and achievements, particularly those relating to legal and 
ethical aspects, application in clinical practice, and consumer scopes in terms of guidelines, 
commercialization and epidemiological factors. Technologies such as next-generation se-
quencing platforms (arrays, bead chips and sequencing approaches) provide a rapid scan of 
known SNPs and CNVs in the genome to show DNA variations in individuals as well as gene 
expression changes  [9, 10] . This paper aims to address endeavors and achievements made 
and to foresee likely progress and challenges in the field of precision nutrition.
 Precision nutrition 4.0 involves Big Data management and ethic foresight analysis for the 
convergence of agrigenomics, nutrigenomics, nutriproteomics and nutrimetabolomics  [11] . 
Indeed, precision nutrition requires the use of genomic information but also phenotypical, 
cultural, behavioral and lifestyle preferences for health maintenance and disease management 
to guide universal and personal advice  [12] .
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 Genetic Tests for Personalized Nutrition 
 In order to offer individual dietary prescriptions, it is necessary to analyze the molecular 
mechanisms and systems interacting in human health  [13] . Uses of molecular biology tech-
nologies include detection of SNPs and identification of candidate genes and polymorphisms 
putatively involved in gene-nutrient interactions, both of which may dictate dietary recom-
mendations based on genotype  [14] . Genetic test panels have emerged that identify genetic 
variance (risk alleles), which may be a key to understanding metabolic diseases and their 
associated therapies. This genetic information, combined with anthropometric, biochemical 
and dietary assessments, will greatly enhance the ability of health professionals to recommend 
a personalized/individualized diet.
 There are two types of genetic tests: in vitro diagnostic tests and laboratory-developed 
tests (LDTs). In vitro tests are produced to be distributed and used by many laboratories; 
the LDTs are used exclusively by the test developer’s laboratory  [15] . Direct-to-consumer 
(DTC) genetic tests are designed by different companies, and their classification is not yet 
established  [15, 16] . The demand for DTC genetic tests has increased to the point where they 
are currently the main tool for genetic screening in personalized nutrition  [16] , primarily 
because they facilitate direct access to an individual’s genetic information  [17] . Such infor-
mation helps predict predisposition to future health problems, thus representing a prom-
ising preventive tool. Similarly, genetic information can indicate which individuals may 
benefit from specific dietary interventions. Hence, dietary recommendations based on 
genotype offer a more effective tool for improving public health  [18] . The Human Genome 
Project has opened up the possibility of a new approach to customized diets that can help 
mitigate the prevalence of obesity and other chronic diseases  [19] . One such example is 
familial hypercholesterolemia, a genetic disease in which personalized nutritional advice 
would be useful  [20] .
 The greatest challenge for any dietary treatment is that of motivating individuals to 
change their dietary habits and behaviors. Similarly, the success of personalized diets is 
dependent on an individual’s motivation and on prospective benefits offered by such dietary 
changes  [21] . Eating is a process that involves psychosocial factors, and therefore, individu-
alization of diet based only on genetic information can generate ethical and operational 
controversies. Nevertheless, health professionals routinely evaluate a range of biological data 
such as height, weight and gender, and biomarkers like cholesterol or vitamin status when 
formulating personalized diets. Nutrigenomics has now provided sufficient value that 
genotype should also be included. There is evidence that nutrigenomic advice is better under-
stood and more likely to be followed compared with general dietary advice  [17, 22] . Among 
numerous other advantages, nutrigenomics is proven to be beneficial in long-term weight 
control  [23] , which has been checked within the Food4me project.
 Those individuals who are identified as having a higher disease risk through a genetic 
test may be more motivated to follow dietetic recommendations  [24] . This fact helps address 
widespread issues associated with changing eating behaviors, including dietary changes 
based on genetics. Given that food consumption is a complex area that involves emotional and 
pleasure-based responses, a multitude of factors must be considered when working with
an individual’s motivation to follow dietary recommendations. In this context, Food4me 
approaches the broader, more complex aspects of food consumption and production in a 
number of ways; these include evaluating the efficacy of personalized nutrition in changing 
behavior and in adherence to advice, and business implications, consumer needs and percep-
tions, and ethical aspects of personalized nutrition in Europe  [25] .
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 Functional Foods in Personalized Nutrition 
 Food choices are based primarily on individual preferences, including sensory likes, 
availability and cultural habits  [26] . New tools are needed to support personalized nutrition 
that recognize consumer demands, define new biomarkers and translate such issues to the 
nutritional market  [27] in order for this approach to be useful to individuals. Furthermore, a 
collaborative effort between the food industry and culinary practice is necessary  [28] in order 
to create a nutritional landscape of personalized nutrition, where the food and pharmaceu-
tical industries develop new products and services according to specific groups and needs, 
including the genetic makeup of the consumer  [27, 29] .
 Functional foods can be defined as foods designed to increase the levels of palatability 
and nutrient bioavailability, beneficially affecting the body, improving health status and 
reducing the risk of disease  [30] . Personalized nutrition is promoting development of func-
tional foods aimed at improvement of health status  [31] . To match this development, the food 
industry needs to create new food production technologies to meet new demands.
 New technologies play a rapidly increasing role in supporting an individual’s food/diet 
preferences. Use of electronic devices such as the Internet and cell phone applications has 
become more common. In recent years, companies have used the Internet to offer person-
alized nutrition services based on DNA analysis of the individual  [32] .
 One such example is the Internet support tool called Personal Online Nutrition Guidance 
(PONG), in which daily menus can be planned according to individual nutritional preferences, 
using genetic information to establish individual goals  [33, 34] . The Technology Assisted 
Dietary Assessment (TADA) project  [35] provides a mobile phone application (Mobile Phone 
Food Record) to assist in the assessment of dietary intake  [36] , which provides personal 
nutritional recommendations to individuals based on their nutrient intake  [37] .
 Central to the current demand for new communication tools, online services and applica-
tions is the question as to whether the easiest choice is the healthiest choice. Frequent use of 
such tools means lesser reliance on the advice of health professionals. This raises the question 
as to whether making changes to an individual’s diet based on advice from programs and 
applications is the best option.
 A particular concern in analyzing diet using online and ‘app’ advice is the efficacy or lack 
thereof in such tools. Recent studies have evaluated the role of a single nutrient in metabolism 
and genomics pathways; however, an individual eats a whole diet that contains a large number 
of different nutrients. This fact indicates the importance of assessing dietary patterns rather 
than single nutrients acting in isolation because observing such combinations of nutrients is 
likely to be more useful. Hence, cluster analysis can be used to study food groups and dietary 
patterns that could be associated with genetic analyses.
 Many new questions are emerging that relate to the creation and marketing of new food 
products. These include scientific verification in support of such products, whether everyone 
should choose a healthy diet or just those with a genetic predisposition to particular diseases, 
and how new products will reach the right people  [38] .
 Applications in Public Health: Population-Based Advice versus Personalized 
Advice 
 Public health nutrition interventions aim to develop strategies that promote good health 
through diet  [39] and to cover the nutritional needs of most of the population. Nutritional 
epidemiology studies mainly focus on evaluating the role of diet and nutrients in disease 
prevention to assist with population health guidelines  [40] and reduce the prevalence of 
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disease. These studies are important because they can assess dietary aspects as well as the 
phenotype and genotype. However, the methods of data collection and food intake evaluation 
concurrent with genetic evaluations are currently limited, hence affecting the accuracy of 
these methods  [41, 42] .
 Nutritional interventions at the public health level utilize dietary guidelines for the popu-
lation, as well as informing individual recommendations in clinical nutrition; however, such 
advice is based on population studies  [42] . Advances in human genetic studies and in omics 
technologies are contributing to the modification and improvements of this framework, but 
the use of genetic tools in public health nutrition policy is not prevalent.  [43] . Application of 
genetic knowledge in public health interventions is a crucial issue. For instance, if scientists 
know that a polymorphism can modify the requirement for a nutrient, or of a situation in 
which a polymorphism increases the risk of diabetes in individuals with a low fiber intake, 
the question arises as to whether such information can be translated to all populations.
 Individualized nutritional recommendations also bring their own issues, such as the diffi-
culty of making simple, general recommendations; the advice to eat five servings of fruits or 
vegetables per day is one such example  [33] . A further issue is the increased complexity of an 
individual’s food choices when gene-nutrient interactions are taken into account.
 The genetic variants that affect nutritional metabolism and requirements can be detected 
both through candidate gene methods and through whole genomics analyses. The candidate 
gene method evaluates associations between genetic polymorphisms and the resultant effects 
in metabolic pathways  [44] . One example of an SNP affecting nutrient requirements is the 
MTHFRAla222Val (C>T) polymorphism that impacts on folate metabolism  [45] . Individuals 
who have the mutant allele T in homozygosis (TT) need a greater folate intake to lower their 
risk of folate-related diseases. Therefore, carriers of this polymorphism may need specific 
folate supplementation rather than those values recommended by RDAs, given that such 
guidelines currently cover both wild and mutant genotypes. Folate intakes for those carrying 
this SNP should be higher, particularly for TT individuals  [46] . To give another such example, 
those who have Down syndrome (trisomy 21) have increased zinc and folate requirements 
 [47] . The activation of the three chromosomes results in an overexpression of cystathionine-
β-synthase, an important gene in folate metabolism  [47, 48] .
 Long-chain omega-3 polyunsaturated fatty acids (PUFAs) are a further example of the 
fact that ‘one size fits all’ cannot be applied in nutritional advice. Those individuals who carry 
the A allele for the APOA1 polymorphism (G>A) show an increase in HDL cholesterol levels 
after increased consumption of PUFAs, while those with the GG genotype show a reduction in 
these levels  [49] . Similarly, individuals with major risk alleles for serum- and glucocorticoid-
inducible kinase 1 (SGK1) display higher systolic blood pressure when on a high-salt diet  [50] .
 SNPs and other genetic variants can also be associated with specific ethnic groups  [51, 
52] . For example, celiac disease, which is characterized by gluten intolerance, affects 2.4% of 
adults in Finland, 0.3% in Germany and 0.7% in Italy  [53] . In European populations, the 
frequency of the mutant allele of Apo E4 is higher in northern countries than in southern 
countries  [54] . The hereditary persistence of lactase is common in individuals from northern 
Europe (90%), occurs in 50% of subjects in the Middle East and Mediterranean, but affects 
less than 20% of African individuals  [55, 56] .
 Dietary requirements suitable for one genotype are unlikely to be appropriate for indi-
viduals with a different genotype  [33] . Some researchers believe that the solution is to find 
common levels of consumption that would work for most genotypes. However, this approach 
is limited by the fact that recommendations still need to differ for those who have a variant 
that increases particular requirements and those who do not. Another approach is to cate-
gorize individuals into subgroups with similar genetic characteristics. These subgroups may 
differ in the activity of transport proteins and/or enzymes that require particular micronu-
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trients as a cofactor  [57] . Optimal dietary recommendations should be based on assessments 
of bioavailability, bioactivity and bioefficacy of nutrients  [13] , and must be individualized 
according to genotype in order to reduce disease risk and to increase health  [58] .
 Dietary reference intake (DRI) recommendations need to be informed by emerging 
knowledge of genetic diversity in individual metabolism and requirements  [33] . A natural 
result of this will be that DRIs offer recommendations towards population groups in which 
the frequency of specific alleles is high.
 A better targeted public health intervention is the main aim of most nutrigenomics 
studies  [59] . Knowledge of genetic and molecular profiles of populations should not only 
benefit control and reduction of disease prevalence, but should also contribute to prevention 
strategies. In this context, the knowledge that nutrigenomics offers is likely to affect the food 
industry, in particular the design and manufacture of products, including fortified foods. It is 
hoped that nutrigenomics will also assist in creating new nutritional policies for diverse 
populations, with disease prevention programs being implemented only for those who show 
evidence of disease risk. Similarly, nutritional supplementation policies would be more 
effective if adequate clinical trials showed who the supplements would be most applicable 
for. Once people understand how useful such policies can be to them as individuals, greater 
adherence is expected to be achieved  [60] .
 Ethical, Legal and Social Aspects in Nutrigenetics 
 The use of a genetic profile in nutritional advice raises ethical, legal and social issues  [33] , 
including use of genetic tests, nutrigenetics research and clinical practice  [61] , collection and 
storage of samples, children’s involvement, and information passed on to the family  [62] .
 Consumer Acceptance and Adherence 
 Public acceptance of new technology is clearly influenced by recipients’ estimation of 
benefits and costs or risks involved. In many cases, there is also a component of moral beliefs 
and attitudes  [63, 64] . There is good public acceptance of genetic testing for hereditary 
diseases  [21] . Several studies indicate that there is also a widespread positive attitude among 
the public toward using genetic tests for personalized nutrition  [65–67] . Socioculturally 
disadvantaged groups seem to interpret genetic testing positively  [68] . Individual reactions 
to innovations in food appear to be associated with conceptions of health benefits, including 
a lowered risk of disease  [69] .
 There is limited evidence, however, that genotype-based dietary advice will motivate 
appropriate behavior changes. A study which compared the effect of knowledge of genetic 
profile on the nutritional behavior of individuals indicated that while most participants liked 
the specific recommendations, those who received detailed information by genotype were 
more likely to respond than those who received standard recommendations  [70] . Another 
study showed that individuals believe that health professionals provide better information 
on genetic profile than DTC genetic tests  [18] . Other authors found no changes in diet, exercise 
or psychological behavior in a genetic test follow-up, concluding that use of DTC genetic tests 
is controversial  [71] . It should be noted, however, that this study may lack current relevance, 
given that it employed a genetic test that has not been continued.
 Consumer Protection 
 Much attention has been given to informed consent as a tool for protection of individuals 
involved in health- and research-related interventions, including access to sensitive infor-
mation and undertaking of burdensome or risky activities. When it comes to genetic infor-
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mation, this discussion has partly focused on the question as to whether genetic information 
is inherently of a special kind or not compared to general health information. Regardless of 
this aspect, it is crucial to handle genetic information with care because such information is 
sensitive, may have far-reaching implications and can easily be misused. Because of such 
considerations, a number of authorities have worked toward making informed consent a 
prerequisite for performing genetic tests. Persons undergoing tests must know the benefits 
and risks of genetic testing, and must also be aware that changes to dietary and other life-
style factors may be suggested based on the results of such tests  [33] . For instance, in Europe 
the treaty on genetic testing for health purposes states that genetic probes may only be 
carried out under quality control, individual supervision, and after informed consent  [72] . 
However, informed consent is often perceived as a formality of limited significance, and a 
number of additional efforts need to be considered in order to achieve adequate consumer 
protection.
 Quality of genetic tests and subsequent nutritional or lifestyle advice is of crucial impor-
tance. Currently, there are approximately two million test panels commercially available  [73] . 
These genetic tests are heterogeneous in relation to polymorphisms analyzed, and some labo-
ratories may use an erroneous database, promoting false results. Some studies are performed 
in a specific population and cannot be extrapolated to other ethnic groups. Genetic tests by 
Spanish and American laboratories of genes found in GWAS studies were summarized by San-
Cristobal et al.  [20] . The authors noted, however, that some genetic polymorphisms evaluated 
in genetic panels were never reported in scientific studies. In addition, some studies have 
been performed in a small population, and the results need to be validated with a larger 
number of people before being applied in commercial tests  [20] . Dietary recommendations 
based on inconclusive or unreliable information may result in unnecessary limitations and 
concerns  [38] . Important questions include: ‘does the test detect just the genotype or more 
when providing the DNA sequence?’ and ‘how can this information be used?’ Understanding 
and reporting are an important part of the genetic test process. Identification of genetic 
variants that may predispose individuals to chronic disease is not well established and may 
therefore pose a significant barrier to nutrigenomics-based personalized nutrition  [62] . For 
clinical application of genetic knowledge, a health professional needs to know how to interpret 
genetic and molecular tests and to extract the necessary information for planning dietary 
interventions  [76] . Because of this, genetic nutritional education is needed for health profes-
sionals at the forefront of advances in nutrigenomics  [74] . Further, it is urgent that courses 
in nutritional genetics are included in the university curriculum  [75, 76] in order to educate 
and orientate a new generation of professionals, the nutrigenomicists  [74] .
 Several ethical questions concern privacy of information. Genetic profiling, including 
prediction of future health events, may interest insurance companies, possible or actual 
employers, and others such as schools or athletic teams  [77] . Consequently, a person may be 
asked to take such genetic tests or to reveal the results of tests already undertaken. This raises 
the risk of discrimination, despite recommendations that genetic profile should be considered 
confidential  [78] .
 Another question arises out of the fact that we share many of our genes with family 
members. Should we thus share personal genetic information with them? How should parents 
act in relation to their children? Should health professionals involve family members? Family 
history is an important tool to determine the risk of hereditable diseases and may help in the 
use of genetic testing to predict future disease  [61] . While genetic tests help to make indi-
viduals better informed  [79] , if the subject has direct access to genetic testing, they may 
misinterpret the results.
 In addition, the spectrum of genes tested can give a person more information than they 
ask for, and may contain unwanted results which can cause anxiety  [80] . For this reason, 
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health professionals must address the ethical questions connected to opportunistic screening, 
i.e. ad hoc tests offered by a medical doctor to a patient without symptoms or a test made upon 
request from an individual patient without symptoms or known risk factors  [38] . There is 
currently no consensus on opportunistic screening among health professionals because 
although a particular test may not seem necessary, individuals may claim the right to ask for 
available services  [81] .
 Guidelines and Legal Regulations 
 Guidelines for the regulation of genetic tests and analyses aim to protect individuals from 
harmful services and include analytical regulations (measure of the accuracy of genetic tests 
to identify genes and polymorphisms), clinical validity (assess the accuracy of interpretation 
and association with clinical status) and clinical utility (evaluate the possibility of reaching a 
desired clinical result with a recommended intervention) as factors of consideration  [82, 83] . 
In 2007, the European Nutrigenomics Organization (NuGO) developed guidelines for nutri-
genomic research  [84] .
 Any country or national regulatory agency can establish legislation for clinical genetics 
 [85] . Producers of genetic testing have specific responsibilities according to prevailing 
ethical/legal rules in their own country. However, legal regulation remains insufficient, with 
genetic test guidelines still in development in many countries. Progress is, however, being 
made, with many government agencies and organizations having published information and 
guidelines regarding DTC to help clarify, inform and alert individuals  [86–89] .
 The USA Supreme Court made a landmark decision in 2013, when it determined that 
DNA in its natural form cannot be patented  [90] . This decision  [90] helped facilitate the inte-
gration of genomics and clinical practice, resulting in laboratories having the freedom to 
create new products for the benefit of the population  [91] . The Medicine and Healthcare 
Products Agency (MHPA) pointed out that nutrigenomics tests are like ‘lifestyle tests’ (not 
clinical testing with the intention to provide dietary advice) and would not have to follow a 
legislation  [83, 87] . However, the Human Genetic Commission disagreed with this position 
and proposed that ‘lifestyle tests’ should be considered in the same way as in vitro diagnostic 
tests and should, therefore, follow legislation  [83] . Currently, three federal agencies are 
involved in regulating genetic tests in the USA: the Food and Drug Administration (FDA), the 
Centers for Medicare & Medicaid Services (CMS), and the Federal Trade Commission (FTC) 
 [92] . The FDA has the broadest authority, under the Federal Food, Drug and Cosmetic Act, 
and exercises this authority depending on how a test comes to market. If a test is sold to 
multiple laboratories as a kit (a group of reagents used in processing of genetic samples that 
are packaged together) the FDA regulates the test. To date, these have comprised a compar-
atively small number of tests. If, as more commonly happens, a test comes to the market as 
an LDT, developed and carried out by a single laboratory, the FDA does not currently regulate 
such a test. Despite the FDA announcing in 2010 that it plans to regulate LDTs, and notice 
given to Congress by the FDA on July 31, 2014, that it would be announcing draft guidelines 
on the regulation of LDTs in the next 60 days  [92] , no further announcement has been forth-
coming at this time. This situation has prompted much discussion and concern in the scien-
tific community that proposed regulation will impact on researchers in academic labora-
tories developing and offering timely testing  [93] . The CMS regulates all clinical laboratories 
performing genetic testing, ensuring their compliance with the Clinical Laboratory 
Improvement Amendments (CLIA) of 1988. However, rather than examining whether 
genetic tests performed are clinically meaningful, the CLIA focuses only on qualifications of 
technicians, quality control of lab processes and proficiency of testing. The FTC’s mandate is 
limited to the ways in which tests are advertised and ensuring that information is not false 
or misleading.
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 In 2002, the EU published a paper on the regulation of genetic tests that addresses 
patients’ rights in many European countries, principally regarding the right to information, 
confidentiality, privacy and informed consent  [78] . The UK’s Human Genetics Commission 
(HGC) issued a document in 2010 with principles relating to genetic tests that included trans-
parency, accessibility and ease of information; it also recommended standardized testing 
techniques  [87] . In 2009, the German government implemented rules related to accreditation 
of laboratories, the need for informed consent and genetic counselling  [94] . In Belgium, there 
is no specific legislation for DTC tests; however, there is a law stating that if a DTC test is of a 
medical nature, a medical physician must be involved  [95] . The Netherlands as a country also 
has no specific regulation; however, some genetic tests are required to carry a permit issued 
by the Dutch Minister of Welfare and Sports  [96] . In a recent summary of the regulatory 
framework in Europe, Food4Me concludes that neither the EU nor its Member States have 
legal instruments specifically dealing with personalized nutrition. Instead, due to its new and 
special characteristics, personalized nutrition falls within the ambit of several legal instru-
ments. Hence, it becomes unclear which legal instruments may apply to any specific person-
alized nutrition offering  [97] .
 The Department of Health of the Australian Government determined that testing should 
ensure safety and quality, and prohibits the sale of DTC testing for serious diseases  [98] . In 
Latin America, most countries do not have any specific rules for genetic tests.
 Commercialization 
 Use of DTC genetic tests has generated controversy, with online companies offering 
tests being subjected to strong criticism for misleading consumers as well as for the imbalance 
between far-reaching promises and contrasting disclaimers  [67] . This has led to discussions 
about the damage that such tests may cause consumers, as well as possible threats to indi-
vidual autonomy  [99] . In this context, 23andMe Inc. is a company which formerly sold a DTC 
genetic test via online platforms able to detect genetic variants associated with more than 
254 specific diseases and conditions, without health professional involvement. In a warning 
letter dated November 22, 2013, the US FDA ordered 23andMe to discontinue the marketing 
of their Personal Genome Service, because it did not comply with regulatory requirements 
regarding safety and effectiveness or possess the required marketing authorization  [99–
101] . In response to this, for the next 2 years 23andMe still sold genetic tests, but they no 
longer offered personalized advice related to results. On October 21, 2015, 23andMe issued 
a press release stating that they are now the first and only company to receive FDA authori-
zation to market a DTC genetic test. The name of the approved test is the Personal Genome 
Service (PGS); it includes carrier status, wellness, trait and ancestry reports. While this FDA 
approval marks a milestone of a kind, 23andMe are careful to state that ‘23andMe is not 
intended to diagnose any health condition. You should consult a healthcare professional 
before making any major lifestyle changes.’ Their press release of October 2015 states that 
their Carrier Status tests cannot determine if someone has two copies of a genetic variant, 
that each test is most relevant for people of certain ethnicities, that tests are not intended to 
diagnose a disease or to predict risk for developing a disease in the future. Further, they state 
that on their own, carrier status tests are not intended to tell clients anything about the 
health of their fetus or their newborn child’s risk of developing a particular disease later in 
life. Several other Internet companies offering genetics-based advice, mainly in the US, have 
also closed down or limited their services. As already discussed, the FDA has not yet 
developed specific rules for genetic testing. FDA approvals given (e.g. cystic fibrosis test and 
high-throughput platform) have been based on an evaluation of analytical validity  [102] . 
Such approval may be a milestone for the regulation of all genetic tests and analyses  [103, 
104] .
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 Social Issues 
 In the context of personalized nutrition, food may be understood as a tool for good health. 
However, food is not only nutrition; it also plays a significant role in shaping and expressing 
social relations, plus cultural and personal identity. Personalized nutrition needs to integrate 
the nutrigenetic approach with everyday cultural, emotional, ethical and sensual under-
standings of food. Individually tailored nutritional advice needs to reach beyond recommen-
dations for intake levels of single nutrients and include suggestions for meals and recipes 
 [105] . In the early days of personalized nutrition, there were strong expectations that a new 
generation of functional foods would acquire a significant role in the field. So far, this evolution 
has not been the case. Instead, the current trend in personalized nutrition, to focus recom-
mendations on choice and intake of food already available, seems to more easily integrate the 
social aspects of eating.
 Concerns have been expressed that personalized nutrition may trigger unhealthy quests 
for health, such as healthism and medicalization of diet  [106] . Currently, personalized 
nutrition appeals largely to a limited population segment, particularly early adopters and 
health seekers. Despite the fact that focusing on health may be a positive action for most 
adopters of personalized nutrition, there may still be those who develop health issues due to 
their exaggerated attention on healthy lifestyle. However, experience to date does not show 
any indication that personalized nutrition will be a specific risk factor in this respect. Never-
theless, the rapidly growing market for and adoption of personal health monitoring equipment 
may change this situation. Hence, it is important that health professionals remain alert to this 
possibility.
 Current Achievements and Progress 
 Existing data support the relationships between particular genetic polymorphisms and 
human metabolism  [107, 108] . Some SNPs directly affect metabolic pathways and may thus 
explain the differences between prevalence of diseases associated with diet and dietary 
requirements among individuals. Other SNPs related to the processes of absorption, digestion, 
transportation and excretion of nutrients and metabolites contribute to a greater under-
standing of the role of bioactive compounds  [41] . Furthermore, individual SNPs related to 
receptors or enzymes can alter the response to a given dietary intervention  [41] .
 Risk factors are based on statistical estimates from epidemiological studies  [109] . Late 
diagnosis can cause patient complications in terms of developing the most appropriate 
treatment and beginning such treatment as soon as possible. Use of genetic tests and tools 
may promote a more rapid diagnosis of disease and thus enable appropriate interventions 
and diets to be implemented earlier and more effectively.
 Many laboratory techniques useful to personalized nutrition have already been developed, 
including mass spectrometry, chromatography, electrophoresis, microarrays and magnetic 
resonance spectroscopy  [110] . Advances in nutrigenetic technologies are providing scientists 
and health professionals with a holistic approach of considering both nutrition and metab-
olism, thus improving nutritional interventions and enabling customization of diet according 
to individual needs  [111] . A noteworthy advancement that personalized nutrition offers is 
that of being able to identify individuals who will benefit from precise intervention strategies 
 [112] . Omics technologies provide identification of disease risk, identification of appropriate 
biomarker assays (encompassing proteomics, lipidomics and metabolomics) and analyses of 
food bioactives and compounds, thereby promoting better understanding of human nutrition 
and informing the development of customized diets.
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 One particular challenge to the application of personalized nutrition remains, which once 
met, is likely to impact the future of nutrigenomics significantly – how to establish a metage-
nomic view that incorporates the following: biotransformation and digestion of food and 
absorption of nutrients; consideration of the entire human physiology and metabolism, and 
both the gut microbiota and human genome, and the interactions between these genomes.
 New Challenges and Possibilities: What Are We Expecting? 
 The main challenges of nutrigenomics and personalized nutrition encompass scientific 
and technological issues, security and benefits of genetic testing, development of new tech-
nologies and assessment methods, related ethical considerations, and socially related 
(economic, educational, lifestyle) data collection and practice  [62] , as summarized here.
 The first step in a nutrigenetics study is evaluating dietary intake of volunteers. Despite 
the evolution of omics technologies and methods, the tools for assessment of food intake 
(24-hour food recall, diet recalls, food frequencies questionnaires) have not developed as 
well/fast as omics technologies and often lack reliability. In population studies, evaluation 
tools should reflect long-term intake, thus enabling gene-nutrient association to be more 
accurate. Development and improvement of tools for better quantification of food intake 
should be the goal of future research  [113] . One group that planned to address this is the 
Food4Me project, as appears in the white paper generated by this consortium  [98] .
 Genotype alone does not enable personalized nutrition to improve health  [114] . Study of 
polymorphisms has limitations. Most nutrition-related diseases are complex, multigenic 
diseases, meaning that the study of the association between genes becomes very important. 
New technologies, which analyze the whole genome, may help the understanding of gene 
interactions, discovering pathways that can influence nutritional metabolism, and hence 
affect nutrient requirements. Single polymorphisms cannot explain complex diseases, dis-
orders and phenotypes; hence, the era of single polymorphism studies is probably coming to 
an end. Genomic studies will continue to identify new associations between genetic variants 
and disease risk. Improvements in genetic tests and analyses must be constant to support 
future applications of nutrigenomics. The development of a risk map, showing all candidate 
or susceptibility genes for a disease, may help future genomic analysis. The SNPsnap web 
service is a new tool that aids analyses of SNPs, providing corresponding sets of SNPs based 
on the quantity of SNPs, allelic frequency and linkage disequilibrium  [115] .
 There is a need to replace current genetic assays with those that can encompass all new 
molecular and bioinformatic knowledge  [116] . New development tools that facilitate col-
lection of data (such as dried blood spots replacing vein puncture) and portable electronic 
devices that assist in the assessment of dietary intake will facilitate future studies in large 
populations. Such studies will bring challenges to laboratories, research funding agencies, 
universities and health professionals  [117] .
 Studies undertaken have established that genetic markers can predict disease devel-
opment  [34] . Alteration in gene expression and consequently in metabolic pathways results 
in changes in the metabolome  [13] . Tools such as disease biomarkers assist with diagnostics 
 [118, 119] . Examples of such biomarkers include serum retinol, zinc and ferritin  [13] . In 
addition, dysregulated insulin secretion and elevated levels of blood glucose are metabolic 
biomarkers of diabetes  [120] ; branched-chain amino acids may be early signs of diabetes and 
obesity  [121] ; blood profile proteins  [122] and circulating levels of angiotensin-converting 
enzyme are useful tools to predict weight loss and to help improve weight loss maintenance 
 [123] . Epigenetics studies may also result in the identification of epigenetic markers for the 
risk, diagnosis and prognosis of diseases  [124] .
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 While the use of genomic signatures for health is still limited  [125] , study of relevant 
biomarkers enables better follow-up to the evolution of disease and allows a better choice of 
interventions. The widespread nature of human genetic variation can still, however, generate 
difficulties in the interpretation of some biomarker outcomes  [13] . One of the future promises 
of personalized nutrition is that of identifying and evaluating valid biomarkers which can 
then be applied in metabolic interventions  [13, 120] .
 Studies assessing the human microbiome are progressing  [126] . The microbiota can alter 
human response to dietary compounds; additionally, food-borne microbial communities can 
modify diet composition. Integrated study of human nutrition that encompasses biotransfor-
mation of foods, ingestion and digestion, physiology, and metabolism, is becoming increas-
ingly necessary  [127] . In this context, study of the intestinal microbial genome is emerging as 
a promising tool for diagnostics and interventions in personalized nutrition  [127, 128] . Lipi-
domics, proteomics and metabolomics are sciences that are still developing; hence, encoding 
the paths of metabolism and food utilization to be applied as biomarkers in dietary interven-
tions involves future challenges for personalized nutrition  [129] .
 Nutrimetabolomics studies focus on biomarker signatures of food components, gut 
microbiome and molecular profile  [130] . Advances in human metabolic profiling offer 
improved opportunities for studying food biomarkers and individuals; thanks to such 
advances, individuals do not always need to be fasting to be studied  [131, 132] .
 The application of nutrigenomics and nutrigenetics in particular diseases such as cardio-
vascular disease is still in its infancy  [133, 134] . Study of the association between genetic and 
environmental characteristics may help in the implementation of future strategies and inter-
ventions to prevent and reduce obesity  [12, 135, 136] , cardiovascular issues  [137] and other 
diseases. For all of these diseases, a combined approach is necessary that integrates reduced 
consumption of high-density foods, adoption of an active lifestyle, and customized dietary 
recommendations based on phenotype and genotype, with an adequate quantity and quality 
of macronutrients  [138] .
 Individual nutrition is linked to social contact and implies practical and emotional 
benefits  [139] . For some professionals, personalization of nutrition may overlap with custom-
ization, resulting in greater autonomy for the individual. The wide range of products and 
services available on the Internet could distance health professionals from their patients. 
Internet companies offer services without the direct involvement of health professionals, 
which can limit interpretation and understanding  [7] . One study found that while customers 
were negative about Internet services, they were not against individualization per se  [140] . 
Other authors have shown that computer-tailored nutrition education had benefits in indi-
vidual motivation to change diet  [140] . However, in ethical terms, autonomy and responsi-
bility should be distributed according to the ability of the patient to handle them  [141] .
 The integration of precision nutrition into routine clinical care is a growing challenge, 
particularly given that this tool has value only when supported by skilled health professionals 
who are experienced with genetics approaches to nutrition and are able to maintain close 
follow-up with the patient  [142] . Some dietitians reported that they do not consider them-
selves qualified to incorporate nutrigenomics into their practice  [143] , while others have no 
interest in personalized nutrition  [75] . Similarly, many physicians lack sufficient training and 
information in either nutrition or genetics with which to interpret data and provide reliable 
advice for personal nutrition. Consumers need to develop trust in the service being offered, 
and thus it is important that nutrigenetics or nutrigenomics service providers achieve this 
confidence in order to ensure successful treatment  [139] .
 Autonomy, beneficence, no misconduct, and justice are the principles of research ethics; 
however, these are changing with the new scenario of nutrigenomics studies associating diet 
and risk of disease  [38] . In the future application of nutrigenetics and nutrigenomics, more 
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attention needs to be given to ethical issues, including cost-effectiveness and social accept-
ability  [144] . Regulation of ethical and legal aspects of genetic testing in personalized nutrition 
is urgently needed; once such rules and norms are established, they may help the application 
of personalized nutrition  [139] .
 According to some authors  [145] , studies should involve all omics technologies at various 
points of a longitudinal follow-up. An ‘integrative personal omics profile’ using a combination 
of omics profiles has revealed several molecular pathways in conditions of health and disease 
 [146] . A further approach is the concept of the ‘exposome’, which includes all accumulative 
environmental exposures that, in association with genetic factors, determine the risk of 
disease  [147] .
 Omics technologies can be used in a number of ways, including testing a single hypothesis, 
a number of hypotheses, or without any predetermined hypothesis at all; they can also be 
applied to a small number of individuals. Such technologies produce a vast amount of data, 
creating the challenge of how to organize data to empower decision-making. How can we 
transform this ‘boom’ of knowledge into a dietary recommendation for a patient? Emerging 
and future recommendations for personalized nutrition are being analyzed ( fig. 1 ).
 The extensive yield of genetic knowledge needs to be translated into useful information 
to be applicable  [148, 149] . Development of new statistical methodologies that can provide 
integrated, joint evaluation of genotype and environment, using all the omics technologies, 
and enabling optimum exploration of data, is necessary  [124] . Integrating multidimensional 
data to characterize the nutritional status of individuals as well as their risk of disease, and 
then customizing an appropriate diet, is a vital part of personalized nutrition  [150] . Concurrent 
with the emergence of new technologies and analysis methods, new companies are emerging 
to help scientists clarify and organize their results. One such tool is the k-cluster analysis, 
which subdivides a set of items into similar subgroups or clusters (similar patterns) models 
 [151] and can be used to conglomerate data on genetic polymorphisms and gene expression.
 Because nutrigenetics are sciences with enormous potential, it becomes increasingly 
important for scientists to work with bioinformaticists. The future of genomic sciences 
depends on the speed and power of new bioinformatics tools  [152] and on how such tools 
will enable health professionals to personalize treatment and diet. Use of these bioinformatic 
and mathematical tools will be essential to support new nutritional strategies and interven-
tions in public health  [153] .
 The application of personalized nutrition depends on multidisciplinary teams of physi-
cians, geneticists, scientists, bioinformaticists, dietitians, pharmacist and other health profes-

































Legal regulation of genetic tests
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 Fig. 1. Existing and future per-
sonalized nutrition recommenda-
tions. 
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translate knowledge acquired into dietary recommendations and nutritional education, and 
carry the information gained through to public health policy interventions and strategies 
( fig. 2 ).
 One barrier to applying genomic technologies in clinical practice is the high cost of 
genome or exome sequencing  [18] . This fact may limit the use of personalized nutrition. Thus, 
another goal for scientists and industries is to reduce the cost of genetic testing, technologies 
and products so that they are more affordable for individuals. However, even with a reduction 
in the cost of genetic testing which is being achieved, it will also be necessary to reduce the 
cost of advisory services for interpretation of such tests  [154] .
 Privacy and protection of genetic data is another crucial issue. A better understanding of 
issues relating to ethics and marketing is imperative before personalized nutrition becomes 
commercially viable for everyone  [125] . Future studies need to assess the efficacy of imple-
mentation of personalized nutrition  [21] . Ultimately, the development of nutrigenetics/
nutrigenomics will bring about new perspectives and progress that will help achieve optimal 
health of the population  [155] , with benefits of precision medicine in different health issues 
 [156] including obesity as the most prevalent metabolic disease  [44] based on nutrigenetics 
aspects. Also, the gene-gene interplay and gene-diet interactions should be taken into account 
for implementation of personalized nutritional interventions and moving towards specific 
nutrigenetic recommendation algorithms  [157–159] .
 Conclusions 
 Public health dietary recommendations are based on the general population. However, 
with the Human Genome Project and other genetic studies, it is becoming evident that indi-
viduals are different in their nutrient requirement and metabolism. Nutrigenomics, including 
all omics technologies, may assist health professionals in offering personalized advice and 















 Fig. 2. Translation of nutrige-
nomics data to dietary advice 
(population) and nutritional in-
tervention (individual). 
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precision nutrition. These opportunities are opening the door to commercial DTC genetic 
tests, new food products and technologies, some of which may be suspect. Precision nutrition 
has a promising future in treating the individual according to their phenotype and genetic 
characteristics, aimed at both the treatment and prevention of disease. However, many 
aspects are still in progress and remain as challenges for the future of nutrition. The inte-
gration of the human genotype and microbiome needs to be better understood. Further 
advances in data interpretation tools are also necessary, so that information obtained through 
tests and technologies can be properly transferred to consumers. Development of new tools 
such as fluxomics is becoming a part of nutrigenomics/nutrigenetics, enabling advances in 
bioinformatics analyses. This framework plus reduction in the costs of omics technologies 
will further the use of these approaches in population studies. An overriding concern remains, 
however, that ethical and legal regulations are not established and are urgently needed to 
provide support for the recently coined precision nutrition and medicine terms, to enable 
universal and personalized applications. Indeed, precision nutrition will integrate genetic 
data with phenotypical, social, cultural and personal preferences and lifestyles, matters to 
provide a more individual nutrition but considering public health perspectives.
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